60 Degrees Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 26.2% | 26.2% | -476.5% |
| FY2023 | -77.3% | -75.0% | -48.4% |
| FY2024 | -196.9% | -190.0% | -138.0% |
| FY2025 | -212.7% | -204.2% | -137.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 26.2% | 26.2% | -476.5% |
| FY2023 | -77.3% | -75.0% | -48.4% |
| FY2024 | -196.9% | -190.0% | -138.0% |
| FY2025 | -212.7% | -204.2% | -137.3% |